MiR-0766 induces p53 accumulation and G2/M arrest by directly targeting MDM4

被引:33
|
作者
Wang, Qingqing [1 ]
Selth, Luke A. [2 ,3 ]
Callen, David F. [1 ]
机构
[1] Univ Adelaide, Sch Med, Ctr Personalised Canc Med, Breast Canc Genet Grp, Adelaide, SA, Australia
[2] Univ Adelaide, Sch Med, Dame Roma Mitchell Canc Res Labs, Adelaide, SA, Australia
[3] Univ Adelaide, Discipline Med, Freemasons Fdn Ctr Mens Hlth, Adelaide, SA, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
MicroRNA; MDM4; p53; cancer; cell cycle; TUMOR-SUPPRESSOR P53; MUTANT P53; MICRORNA EXPRESSION; NEGATIVE REGULATION; POSITIVE FEEDBACK; GENE-EXPRESSION; MIR-34A; PROLIFERATION; ONCOPROTEIN; TRANSITION;
D O I
10.18632/oncotarget.15530
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p53, a transcription factor that participates in multiple cellular functions, is considered the most important tumor suppressor. Previous evidence suggests that post-transcriptional deregulation of p53 by microRNAs contributes to tumorigenesis, tumor progression and therapeutic resistance. In the present study, we found that the microRNA miR-766 was aberrantly expressed in breast cancer, and that overexpression of miR-766 caused accumulation of wild-type p53 protein in multiple cancer cell lines. Supporting its role in the p53 signalling pathway, miR-766 decreased cell proliferation and colony formation in several cancer cell lines, and cell cycle analyses revealed that miR-766 causes G2 arrest. At a mechanistic level, we demonstrate that miR-766 enhances p53 signalling by directly targeting MDM4, an oncogene and negative regulator of p53. Analysis of clinical genomic data from multiple cancer types supports the relevance of miR-766 in p53 signalling. Collectively, our study demonstrates that miR-766 can function as a novel tumor suppressor by enhancing p53 signalling.
引用
收藏
页码:29914 / 29924
页数:11
相关论文
共 50 条
  • [21] Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4
    J-C Marine
    S Francoz
    M Maetens
    G Wahl
    F Toledo
    G Lozano
    Cell Death & Differentiation, 2006, 13 : 927 - 934
  • [22] MiR-483-3p inhibition ameliorates myocardial ischemia/reperfusion injury by targeting the MDM4/p53 pathway
    Zhang, Haishan
    Wang, Jia
    Du, Aolin
    Li, Yang
    MOLECULAR IMMUNOLOGY, 2020, 125 : 9 - 14
  • [23] Mechanisms of G2 arrest in response to overexpression of p53
    Taylor, WR
    DePrimo, SE
    Agarwal, A
    Agarwal, ML
    Schönthal, AH
    Katula, KS
    Stark, GR
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 (11) : 3607 - 3622
  • [24] GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest
    L Meng
    J K Hsu
    R Y L Tsai
    Oncogene, 2011, 30 : 1716 - 1726
  • [25] Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status
    Mejia-Hernandez, Javier Octavio
    Raghu, Dinesh
    Caramia, Franco
    Clemons, Nicholas
    Fujihara, Kenji
    Riseborough, Thomas
    Teunisse, Amina
    Jochemsen, Aart G.
    Abrahmsen, Lars
    Blandino, Giovanni
    Russo, Andrea
    Gamell, Cristina
    Fox, Stephen B.
    Mitchell, Catherine
    Takano, Elena A.
    Byrne, David
    Miranda, Panimaya Jeffreena
    Saleh, Reem
    Thorne, Heather
    Sandhu, Shahneen
    Williams, Scott G.
    Keam, Simon P.
    Haupt, Ygal
    Haupt, Sue
    CANCERS, 2022, 14 (16)
  • [26] GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest
    Meng, L.
    Hsu, J. K.
    Tsai, R. Y. L.
    ONCOGENE, 2011, 30 (14) : 1716 - 1726
  • [27] Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53
    Wang, Xinyan
    Zhu, Jianwei
    THORACIC CANCER, 2018, 9 (06) : 676 - 683
  • [28] Regulation of the G2/M transition by p53
    Taylor, WR
    Stark, GR
    ONCOGENE, 2001, 20 (15) : 1803 - 1815
  • [29] Regulation of the G2/M transition by p53
    William R Taylor
    George R Stark
    Oncogene, 2001, 20 : 1803 - 1815
  • [30] MDM2和MDM4对P53调控研究进展
    赵婧
    屈艺
    母得志
    医学研究杂志, 2011, 40 (10) : 141 - 143